|
Research Highlights
O'Leary to Lead Lab Service
March 10, 2004
Timothy O'Leary, MD, PhD has been named director of VA's Biomedical Laboratory Research and Development Service (BLR&D). O'Leary holds a doctorate in physical chemistry from Stanford University and a medical degree from the University of Michigan. He is certified in Anatomic Pathology by the American Board of Pathology, and in Molecular Genetic Pathology by the American Board of Pathology and the American Board of Medical Genetics. Following his appointment to the Department of Army Senior Executive Service, he chaired the Department of Cellular Pathology at the Armed Forces Institute of Pathology for more than 15 years prior to coming to the Department of Veterans Affairs. He is also a reserve member of the Public Health Service Commissioned Corps, which recalled him to active duty for four months in 2003.
BLR&D is a new service created through a reorganization of the former Medical Research Service. O'Leary will oversee all VA research that explores basic biological or physiological principles in humans or animals but that does not involve intact human beings. The service includes research on animal models and investigations of tissues, blood or other biologic specimens from humans.
O'Leary's own research interests include molecular changes in gastric tumors, ultrasensitive detection of biological toxins, and mechanisms of formaldehyde fixation. He is credited with expanding the capacity of the Armed Forces Pathology Institute to include molecular genetics and tissue magnetic resonance microscopy.
O' Leary has co-authored or authored more than 130 scientific papers since 1973 and written numerous book chapters. He edited the 2002 text Advanced Diagnostic Methods in Pathology: Principles, Practice and Protocols.
"We're very pleased to have Dr. O'Leary with us," said Jonathan Perlin, MD, PhD, Acting Chief Research and Development Officer. "He's an accomplished scientist, and his experience and achievements will serve us well as we chart the course of the new Biomedical Laboratory Research and Development Service."
|
